annual report - home | university of technology sydney · conference presenations 2016 18. annual...

ANNUAL REPORT 2016-2017

CONTENTS

DIRECTOR’S REPORT 1

CHERE AWARDS 2016/2017 4

NEW GRANTS in 2016/2017 7

ACHIEVEMENTS 10

JOURNAL EDITORSHIPS 10

COMMITTEE MEMBERSHIPS 11

VISITORS TO CHERE 11

VISITING SPEAKERS 11

CURRENT PHD STUDENTS 12

PEER-REVIEWED PUBLICATIONS 2017 13

CHERE WORKING PAPERS 2017 14

CONFERENCE PRESENTATIONS 2017 14

PEER-REVIEWED PUBLICATIONS 2016 14

BOOK CHAPTERS 2016 17

CHERE WORKING PAPERS 2016 17

APHCRI REPORTS 2016 17

CONFERENCE PRESENATIONS 2016 18

ANNUAL REPORT | 2016-2017 page 1

DIRECTOR’S REPORT

Rosalie Viney

2016 was both an important year for CHERE, both in terms of celebrating successes and marking a very important milestone of 25 years of contributing to excellence in health economics research, capacity building and contributing to health policy in Australia through research and engagement. The 25th Anniversary of CHERE was celebrated over two days in November and we were delighted to welcome back Professor Tom Buchmueller, who had previously visited CHERE to launch our new Distinguished Lecture Series to mark the occasion. The Distinguished Lecture will become biennial event for CHERE. Tom’s lecture was perfect for the occasion, and highly relevant to the times – reflecting on the successes of the Affordable Health Care Act, on the eve of the US Presidential elections. We were also delighted to welcome back many of our former staff, student and academic visitors to contribute to a program of reflection on CHERE’s history as well as focus on our current research. I would like to thank and congratulate all of our staff for contributions to the 25th Anniversary celebrations, as well

as to the University and the UTS Business School for their support of CHERE. Special mention to our administrative staff, Gretchen Togle, Liz Chinchen and Vanessa Nolasco for their amazing hard work and coordination, and also to Richard De Abreu Lourenco who who went above and beyond with preparations, including coordinating the 25th Anniversary Memento booklet, and many other activities.

While the 25th Anniversary was a major event in the year, there was much else to be celebrated throughout the year. Of particular note was Professor Jane Hall’s recognition as one of the Australian Financial Review’s Women of Influence finalists, and Associate Professor Kees Van Gool’s recognition through the Sax Institute’s Research into Action Award. Jane was also elected as a member of the Academy of Health and Medical Sciences. In addition, the CREST team was nominated as a finalist in the UTS Research Awards in the Research Excellence through Collaboration category. We were also delighted that Dr Naomi Van der Linden, one of our very talented post-doctoral researchers was awarded a UTS Chancellor’s Post Doctoral Fellowship. Congratulations also goes to Stephen Goodall for his promotion to Professor, which is fantastic recognition of his achievements as a research leader within the University and nationally, and to Richard De Abreu Lourenco who completed his PhD and was promoted to level C as leader of the PBAC evaluation team. It is always pleasing to end the year with positive outcomes in nationally

competitive grants, and it was fantastic news that Jane Hall and Kees Van Gool were awarded an ARC Discovery Grant with long-time CHERE collaborator Professor Denzil Fiebig, to continue outstanding research on the impact of the Medicare Safety Net. These are a few of the many achievements of our staff in 2016, and others are noted elsewhere in this Annual Report. I congratulate all of our staff on their hard work, pursuit of excellence and the enthusiasm and collegiality that they bring to CHERE each and every day.

The management of a successful research Centre takes a great deal of coordination, and could not be achieved without the support and advice of the CHERE management group. Kees Van Gool and Stephen Goodall excel in their leadership, their mentoring of staff and their day to day management of the Centre. Jane Hall continues to provide outstanding strategic vision and guidance for the Centre. I am very grateful to each of them for their commitment to achieving CHERE’s vision. The management group is supported by the experience, expertise and wisdom of our other senior staff, Marion Haas and Mike Woods, and we are very pleased that Professor Debbie Street has accepted a position which will commence in 2017, which cements her longstanding

collaboration with CHERE and brings new strengths to the Centre.

Contact us:

www.chere.uts.edu.au

Director:

Professor Rosalie Viney

Address:

CHERE UTS

PO Box 123

Broadway. NSW 2007

t: +612 9514 4720

e: [email protected]

mailto:[email protected]


In November 2016 CHERE celebrated 25 years of health economics with a two-day symposium held at the Dr Chau Chak Wing Building.

The celebration began with the launch of

CHERE’s Distinguished Lecture Series which

was given by Professor Tom Buchmueller who

is the Waldo O. Hildebrand Professor of Risk

Management and Insurance at the University

of Michigan’s Stephen M. Ross School of

Business. Tom presented a very interesting

and thought-provoking lecture titled “Health

Care Reform in the U.S.: The Effect of

Obamacare on Insurance Coverage and Other

Outcomes”.

The UTS Health Strategy was also launched at

the Symposium by Professor Glenn Wightwick

with an introduction to the strategy provided by

Professor Liz Sullivan.

Past and present staff members, as well as

members of CHERE’s Advisory Board also

presented on a variety of topics on the second

day:

• Why health economics matters – Prof

Rosalie Viney

• Is the price right? How do patients

navigate the Australian Health Care

System after a health shock? – A/Prof

Kees van Gool

• Understanding high cost high

complexity – Dr Tom Longden

• Got it! Getting the value of utility – Prof

Madeleine King (University of Sydney,

CHERE 1991-2008)

• Turning population preferences into

utility – Brendan Mulhern

• Choosing a GP – Prof Stephen

Goodall

• Contraceptive choices – Prof Marion

Haas

• Patient preferences for meta health

effects – Dr Richard De Abreu

Lourenço

• From PhDs to PROMS A/Prof Richard

Norman (Curtin University, CHERE

2006-2014)

• The mental health of children with

disabilities: A public health approach –

Sheena Arora

• Case study: Colorectal cancer

screening – Paula Cronin

• Reflections from the Board – Emeritus

Prof Lloyd Sansom, University of

South Australia, CHERE Advisory

Board

A panel discussion: Jane Hall, Tom Buchmueller (University of

Michigan), Mark Booth (Commonwealth Department of Health), Liz

Koff (NSW Health), Chair: Prof Mike Woods

Paula Cronin


Prof Jane Hall

Prof Tom Buchmueller

Sheena Arora

Prof Jane Hall, Kerri Kellett, Mark Booth

Profs Rosalie Viney, Tom Buchmueller, Jane Hall and

Glenn Wightwick

Sopany Saing, Sheena Arora, Dr Naomi van der Linden,

Rebecca Addo and Kathleen Manipis

Jody Church, Elena, Meshcheriakova and Paula Cronin


CHERE AWARDS 2016/2017

2016 Vice-Chancellor’s Awards for Research Excellence

The CREST team was nominated for the Vice-Chancellor’s award for research Excellence

Patsy Kenny, Dr Richard De Abreu Lourenço, Dr Jason Abbott, Dr Naomi van der Linden, Dr Alison Pearce, Dr Phil Haywood, Prof Rosalie Viney, Alex Waber, Prof Marion Haas and Dr Chris Brown

Inaugural Business School Distinguished Scholar Award

In November 2016 the Business School announced Prof Rosalie Viney as the winner of the Inaugural Distinguished Scholar award. This award publicly acknowledges Rosalie’s work as well as the work of CHERE.

Dr Tom Longden, Patsy Kenny, Martin Flattery, Kathleen Manipis, Prof Stephen Goodall, Sopany Saing, Dr Naomi van der Linden, Brendan Mulhern, Prof Rosalie Viney and Dr Alison Pearce

Fellowship in the Australian Academy of Social Sciences

This award recognises Prof Rosalie Viney’s significant contributions to the field of health economics research and policy development in Australia and internationally.

Distinguished Professor Award at UTS

This achievement is a testament to Jane’s hard work - her research interests have placed her in the forefront of health policy in Australia.

The Australian Financial Review 100 women of Influence for 2016

Prof Jane Hall was recognised as one of 100 Women of Influence in the Public Policy category.

Vice-Chancellor’s Career and Professional Development Awards for High Performing Staff

Vanessa Nolasco was recognised for her contribution to the work of the University

Vanessa Nolasco and Anne Dwyer

Sax Institute Research Action Award

A/Prof Kees van Gool was awarded a Research Action award by the Sax Institute for his work on the Medicare Safety Net

Winners A/Prof Kees van Gool (L) and Angela Dawson (R) with Dr Abdul Ghaffar at the awards ceremony


NEW PROJECTS IN 2016/2017

Provision of External Evaluation of Pharmaceutical Benefits Advisory Committee (PBAC) and Health Technology Related Submissions for the Department of Health

The Pharmaceutical Benefits Advisory Committee (PBAC) is an independent statutory body established to make recommendations and give advice to the Minister about which drugs should be listed on the Pharmaceutical Benefits Scheme. PBAC makes recommendations based on the effectiveness and cost-effectiveness of new drugs.

CHERE originally won a competitive tender to become an independent evaluator for PBAC in 2009. The contract was renewed in November 2016 for a further four years. CHERE evaluates and prepares high quality commentaries on a number of major submissions each year. The evaluations involve analysis and review of complex clinical and economic data, including modelled analyses. The work is cyclical and has to be completed within a tight, strictly adhered to timeframe corresponding to each PBAC meeting, which are held every four months. Funding source: Commonwealth Department of Health CHERE staff: Stephen Goodall, Richard De Abreu Lourenço, Jane Hall, Naomi van der Linden, Paula Cronin, Sheena Arora, Kathleen Manipis, Sopany Saing, Martin Flattery, Marion Haas, Jody Church, Phil Haywood, Elena Meshcheriakova, Deborah Street, Patsy Kenny

Evaluation of the Western NSW Integrated Care Strategy

This project is a three-year evaluation of the Western NSW Integrated Care (IC) Strategy. The evaluation considers process, impacts, outcomes and the following economic indicators: strategy implementation, patient journey through care, health and service utilisation outcomes and costs and benefits.

Funding source: Western NSW Local Health District CHERE staff: Jane Hall, Kees van Gool, Serena Yu Collaborators: Mark Harris1, David Lyle2, Megan Passey2, Gawaine Powell-Davies1, Tony Lower2, Julie McDonald1, Karen Gardner1, Sue Kirby2, Terry Findlay1, Karen

Edwards3

1. University of NSW 2. University of Sydney 3. Counterpoint Consulting Pty Ltd

Evaluation of the Brisbane North Team Care Coordination

This evaluation will address some of the many challenges previous evaluations of integrated care models nationally and internationally have confronted. It addresses: gaps in knowledge about what makes integrated care effective and cost-effective and lack of evidence on the patient population groups for whom integrated care is most effective and cost-effective provide a better understanding of how integrated care models can successfully move from demonstration projects to sustainable models of care.

Funding source: Partners 4 Health Limited CHERE staff: Kees van Gool, Jane Hall, Tom Longden

NSW Health Activity Based Funding (ABF) costing project This project is investigating the methods for improving healthcare costing practices. Working closely with NSW Health, these advancing programs aim to better educate healthcare administrators and clinicians on the impact of better healthcare costing systems on the delivery of healthcare services.

Funding source: NSW Health CHERE staff: Jane Hall Collaborators: Prabhu Sivabalan1

1. UTS Business School

Estimating the willingness to pay to avoid the negative impacts of foodborne disease

This project consists of a number of Discrete Choice Experiments (DCEs) that will include a range of attributes to understand the impacts of foodborne illnesses. Respondents will be presented with a series of profiles describing the impacts of particular foodborne illnesses and asked to choose which they prefer. This will include an investigation of particular sequelae relating to foodborne illnesses. Funding source: Food Standards Australia New Zealand (FSANZ) CHERE staff: Stephen Goodall, Rosalie Viney, Brendan Mulhern, Kathleen Manipis

Health Outcomes Analytics

This project will provide a critical analysis of the draft Health and Wellbeing Outcomes Framework, with particular focus on program


and system level indicators, in line with the Institute for Healthcare Improvement’s (IHI) Quadruple Aim approach. This project will enable PHN staff to develop the PHN’s workforce’s capacity to review and identify program data and metrics.

Funding source: Hunter New England and Central Coast Primary Health Network CHERE staff: Kees van Gool, Jane Hall

Provision of a consultancy for the evaluation project for the Health Care Home model This is a three year evaluation of the Health Care Home model and will be focussed on identifying changes in structure and processes that have occurred, arising out of the HCH model, and estimate the early impacts on patient outcomes. CHERE will undertake the economic evaluation of the model.

Funding source: Commonwealth Department of Health CHERE staff: Jane Hall, Kees van Gool, Tom Longden

Collaborators: Jim Pearse1, Lewis Kaplan1, Deniza Mazevska1

1. Health Policy Analysis

Health Technology Assessments and critiques for MSAC

The role of MSAC is to provide recommendations to the Australian Minister for Health and Ageing regarding the evidence relating to the safety, effectiveness and cost-effectiveness of health technologies and medical procedures. The recommendations of MSAC are used by the Australian federal government to decide whether public funding via MBS should be granted. Funding source: Royal Australasian College of Surgeons CHERE staff: Stephen Goodall

National Registration and Accreditation Scheme: Review of Accreditation Systems

The Review of Accreditation Systems aims to provide advice to AHMAC on the cost effectiveness of an accreditation system to ensure that the educational programs provide a sustainable registered health profession workforce that is flexible and responsive to the changing health needs of the Australian community. The Review will address the: cost effectiveness of the regime for delivering the accreditation functions; opportunities for the

streamlining of accreditation including consideration of the other educational accreditation processes e.g. Tertiary Education Quality Standards Agency (TEQSA) and Australian Skills Quality Authority (ASQA); the extent to which accreditation arrangements support educational innovation in programs including clinical training arrangements, use of simulation and inter-professional learning; and assessing opportunities for increasing consistency and collaboration across professions.

Funding source: Department of Health and Human Services Victoria CHERE staff: Mike Woods

Assisting in developing a trial in early stage non-small cell lung cancer (NSCLC) which will compare surgery with a form of radiation therapy called stereotactic ablative radiotherapy (SABR)

The aim of this project is to undertake some preliminary research to assist in developing a trial in early stage non-small cell lung cancer (NSCLC) which will compare surgery with a form of radiation therapy called stereotactic ablative radiotherapy (SABR).

Funding source: Trans-Tasman Radiation Oncology Group Ltd CHERE staff: Marion Haas, Richard De Abreu Lourenço, Rosalie Viney

Scoping literature around costs/health care resource use in cancer patients with an anxiety disorder

The aim of this project is to conduct search of the published literature focusing on the costs of care and health care resource use among patients with cancer diagnosed with anxiety disorder. A data extraction tool will be developed for use in extracting the relevant information.

Funding source: University of Sydney CHERE staff: Richard De Abreu Lourenço, Alison Pearce

Detailing the costs of preparing paediatric transplant materials

The aim of this project is to estimate the costs of obtaining and preparing a donor product for paediatric allogeneic bone marrow transplantation using current processes, and those required for α+β+/CD19+ depleted haploidentical bone marrow transplantation.


Funding source: Cancer Australia CHERE staff: Richard De Abreu Lourenço

Explaining recent trends in enterprise

agreement making

This project analyses recent trends in employees covered by enterprise agreements. An explanation for the recent trends in employees covered by enterprise agreements considering, but not limited to, changes that have occurred in the manufacturing and services sectors, increases in part-time employment and declines in union density is provided. It also provides analysis using the EEH microdata for 2016 to explore more recent changes in collective bargaining further detail.

Funding source: Fair Work Commission CHERE staff: Serena Yu

NEW GRANTS in 2016/2017

The Medicare Safety Net and its impact on moral hazard, equity and welfare

The Extended Medicare Safety Net (EMSN) was introduced in 2004 and fundamentally changed health insurance arrangements in Australia. For those qualifying for the EMSN, insurance benefits were no longer linked just to the volume of services consumed but, for the first time, also to the fees charged by doctors. Previous research has shown that the EMSN led to a substantial rise in doctor fees and that benefits were regressively distributed. As a result, the government introduced several reforms that limited the amount of benefits that patients could claim. This research will build on our previous research by examining the broader impact of the EMSN from within a welfare framework, examining its effect on equity, risk and moral hazard.

Funding source: Australian Research Council (ARC) Investigators: Jane Hall, Denzil Fiebig, Kees van Gool

A sustainable and supported clinical pathway for managing anxiety and depression in cancer patients: Developing and evaluating components and testing implementation strategies

This research program seeks to ensure that all cancer patients suffering from anxiety or depression are identified and receive

appropriate care. Sustainable and effective resources and systems will be developed and implemented in a manner that empowers patients and family members towards self-care, up-skills all Oncology health professionals, and allows specialist psychosocial staff to focus on the people who most need their expert input. The best ways to make this work in the health system will be established.

Funding source: Cancer Institute NSW Investigators: Phyllis Butow, Gavin Andrews, Afaf Girgis, Brian Kelly, Thomas Hack, Josephine Clayton, Melanie Price, Philip Beale, Rosalie Viney, Alison Pearce, Laura Kirsten

Reducing Inappropriate Polypharmacy for Older Australians

This project aims to determine the extent and potential impact of inappropriate polypharmacy (use of harmful or unnecessary medicines) in older inpatients with and without dementia, and to develop tools to sustainably address inappropriate polypharmacy in routine care. Reducing polypharmacy in older inpatients, especially those living with dementia or near the end of life, will improve clinical outcomes and reduce costs to patients.

Funding source: NSW Health Translational Research Grant Investigators: Sarah Hilmer, David Le Couteur, Danijela Gnjidic, Andrew McLachlan, Rosalie Viney, Melissa Baysari, Alexandra Bennett, Fiona Blyth

The CRISP Trial: an RCT of risk assessment and decision support to implement risk-stratified colorectal cancer screening in primary care

The CRISP Trial is an RCT in general practice aimed at measuring the impact of a consultation using the CRISP tool on risk-appropriate bowel cancer screening, measured objectively using routine health data. Secondary outcomes will include effects on patient psychosocial outcomes and healthcare costs.

Funding source: Victorian Cancer Agency Health Services Investigators: Jon Emery, Finlay Macrae, Lyndall Travena, Marie Pirotta, Driss Ait Ouakrim, Fione Walter, Patty Chandros, Jennifer Walker, Ingrid Winship, Richard De Abreu Lourenço


Support for the Translational Cancer Research Network (TCRN)

The aim of this project is to provide support for the TCRN by carrying out: audits of trial protocols; reviews of clinical trials, surveys or observational research that might already have commenced, or be nearing completion, for suitability for an economic evaluation. It includes the provision of ongoing advice to CIs and trial management staff on the steps required to conduct an economic evaluation. The collaborators will also review grant applications and develop some general and tailored workshops and seminars for TCRN members.

Funding source: Cancer Institute NSW Investigators: Richard De Abreu Lourenço, Marion Haas

SCORE: Shared care of Colorectal cancer survivors – A randomised controlled trial of hospital-based follow up versus shared hospital / community follow up for survivors of colorectal cancer

After finishing treatment, bowel cancer survivors can experience a range of issues including ongoing side effects, emotional, psychological and practical concerns. Most people have follow-up with their cancer specialists (surgeon or oncologist). However, people often report needs that are not met. Follow up with general practitioners (GPs) is a reasonable option for some survivors. A combination of follow up with cancer specialists and GPs (called shared care) may offer a range of advantages and may be cheaper than the standard follow up model. This study will compare standard follow up to a shared care model for bowel cancer survivors.

Funding source: Victorian Cancer Agency Health Services Investigators: Michael Jefford, Penelope Schofield, Jon Emery, Eva Grunfeld, Alexander Heriot, Andrew Martin, Richard De Abreu Lourenço, Dorothy King

Synthesising the evidence from research testing DCE for the valuation of health The aim of this project is to test a range of discrete choice experiment study designs that can be used for the valuation of health states from preference based measures such as the EQ-5D. This involves testing designs developed using a number of different strategies firstly using simulation methods and secondly using primary data collection

Funding source: EuroQol Research Foundation Investigators: Brendan Mulhern, Rosalie Viney

Valuing EQ-5D-5L in Australia: A comparison of the EQ-VT protocol and DCE with duration

The aim of this project is to collect preference data from an Australian general population sample using the EQ-VT protocol. The sample for the EQ-VT will be drawn from the sample undertaking the online DCETTO, enabling within person comparison of methods. To estimate utility values, we will model the TTO and DCE data separately, and also use ‘hybrid’ models. EQ-5D-5L value sets produced using the EQ-VT and DCETTO protocols will be compared statistically to disentangle the extent to which different valuations (using similar functional forms) are driven by elicitation method, and the underlying model of preferences.

Funding source: EuroQol Research Foundation Investigators: Rosalie Viney, Brendan Mulhern, Richard Norman, Emily Lancsar, Julie Ratcliffe, Yan Feng

Comparing DCE designs that can be used to value EQ-5D-5L

The use of Discrete Choice Experiments (DCE) to estimate values for EQ-5D has grown in recent years. To estimate the parameters with confidence, a key feature of these studies is the method used to select the choice sets to be valued. However, studies comparing designs developed for the purpose of valuing EQ-5D that use different construction methods and different software have not been carried out. Also, the impact of sample size across designs has also not been fully investigated. The aim of this project is to use simulation methods and primary data to compare three prominent approaches to the design of DCE studies using EQ-5D-5L.

Funding source: EuroQol Research Foundation Investigators: Brendan Mulhern, Rosalie Viney, Deborah Street, Richard Norman

The relationship between the EQ-5D and surgical outcomes in a large Australian registry of percutaneous intervention patients

This project will explore the effect of percutaneous interventions (PCI) (typically


stenting) on quality of life as measured by EQ-5D in a large Australian registry of cardiac patients (the Victorian Cardiac Outcomes Registry (VCOR)). The project will explore patients’ characteristics associated with improvements in EQ-5D outcomes (both dimension level changes and utilities).

Funding source: EuroQol Research Foundation Investigators: Brendan Mulhern, Richard Norman

A qualitative approach to understanding what aspects of health are important to people

The aims of this research project are: To understand what concepts and definitions should form the basis for a EuroQol generic classification system; to develop and pilot an approach to identifying what aspects of health are important to people; to obtain the views of patients and members of the public about what aspects of health are important to them; and to produce a list of candidate items for potential inclusion in a generic classification system. The study will inform the ongoing research agenda around the measurement of health and health-related quality of life beyond the existing EQ-5D descriptive system.

Funding source: EuroQol Research Foundation Investigators: Brendan Mulhern, Koonal Shah, Amanda Cole, Bas Janssen, Louise Longworth, John Brazier, Nancy Develin

A qualitative approach to understanding what aspects of health are important to people – Australian extension

Given the need to understand what aspects of health are important to people internationally, the aim of this research project is to extend the Shah et al proposal (see above) to repeat Stage 3 with an Australian population (including general population and patient groups) using the same survey. The study is a low-cost extension to collect data from a second English speaking country using the same methodology (in line with DSWG recommendations), and will inform the ongoing research agenda around the measurement of health and health-related quality of life beyond the existing EQ-5D descriptive system.

Funding source: EuroQol Research Foundation Investigators: Brendan Mulhern, Koonal Shah, Bas Janssen

Development of an Ethical Framework and Resources for Decision-making in the Application of Genomic Sequencing and Personalised Medicine in Paediatric Oncology

This innovative, mixed-method study will specifically explore the preferences and decision-making of parents and oncologists with regard to genomics and PM, firstly using a qualitative interview methodology to identify key factors or attributes, then systematically evaluating these attributes on a larger and broader sample of parents and clinicians using an empirical discrete choice experiment design. This data will then be subjected to a rigorous ethical analysis that will result in the development of an ethical framework to guide clinical practice. Lastly, informational and educational resources will be developed and piloted to assist clinician practices and family decision-making in this complex but new era in paediatric oncology.

Funding source: Victorian Cancer Agency Health Services Investigators: Maria McCarthy, Lynn Gillam, Francoise Mechinaud, Richard De Abreu Lourenço, Sylvia Metcalfe, Paul Ekert, Rachel Conyers, Peter Downie, Michael Sullivan, Jane Williamson, Helen Irving

Preparation and scoping for the Health Economics portion of the ASCOLT Study

This project is part of a Cancer Australia funded randomised controlled trial which is evaluating the use of aspirin to prevent disease recurrence in patients who have undergone treatment for colorectal cancer. The focus will be on the analysis of data on resource use and quality of life (EQ-5D-5L) collected as part of the trial, to assess the cost-effectiveness of aspirin in this setting.

Funding source: Cancer Australia Investigators: Richard De Abreu Lourenço, Eva Segelov, Val Gebski, John Simes

How long does it take to replace a worker?

Sick leave is estimated to cost Australian businesses more than $30 billion yearly. Lost productivity arises when a person is unable to work for a period of time. There is no global consensus on how lost productivity should be captured in an economic evaluation and outcomes from different methods diverge considerably. Data used to inform worker replacement in Australian economic evaluations are from overseas. However, these data are not directly applicable as time


and costs associated with replacing workers are context dependent. This study aims to develop Australia-specific inputs for estimating the time and costs associated with replacing workers by surveying 200 Australian employers.

Funding source: UTS Business School Research Grant Investigators: Kathleen Manipis, Alison Pearce

Do participants understand health economics surveys?

Understanding people’s preferences for healthcare is crucial to making effective policy decisions around health resource allocation. Health economists often use choice surveys to elicit people’s preferences for healthcare. Research suggests some people find these complex surveys confusing, and hence answer them inaccurately. To assess understanding, questions about the perceived difficulty of the survey are often included. However, in our previous research, participants reported difficulty with the survey didn’t always match the accuracy of their answers. By exploring how to assess and analyse participant understanding of choice surveys, this project will ensure consumers’ preferences are accurately reflected in health policy and practice.

Funding source: UTS Business School Research Grant Investigators: Alison Pearce, Brendan Mulhern

When the clock is ticking: Impact of the extended Medicare Safety Net on the updated of assisted reproductive technology

This project investigates the trends in Assisted Reproductive Technology (ART) services usage with the introduction of Extended Medicare Safety Net in 2004 which provided greater subsidy for ART services and the subsequent implementation of caps in 2010 which reduced the subsidy. It also examines the determinants for women’s decision to use ART services including sociodemographic characteristics. We utilise a unique dataset -linkage data of Australian Longitudinal Study on Women’s Health, a longitudinal survey, with administrative datasets, Medical benefits Schedule and Pharmaceutical Benefits Schedule and deploy the hurdle model to examine the incidence of ART use and the frequency of use among women. The study will shed light on the effect of government policies

on ART services in terms of utilisation and will also examine the determinants driving the decision to undertake these services.

Funding source: UTS Business School Research Grant Investigators: Chun-Yee Wong, Megan Gu

ACHIEVEMENTS

Dr Naomi van der Linden

Naomi is the recipient of a prestigious Chancellor’s Research Fellowship that examines the value of pharmaceutical risk-sharing policies.

Dr Richard De Abreu Lourenço

Richard completed his PhD in December 2016. His thesis examined the value of meta-health effects in health care decisions. He graduated in May 2017.

JOURNAL EDITORSHIPS

Prof Jane Hall is an editor of two international peer-reviewed journals, Health Policy and Health Economics

Prof Rosalie Viney is an Associate editor of Health Economics

Dr Alison Pearce is an editorial board member of PharmacoEconomics Open


COMMITTEE MEMBERSHIPS

Prof Rosalie Viney

Member of the Pharmaceutical Benefits

Advisory Committee (until Feb 2017)

Chair of Pharmaceutical Benefits Advisory

Committee's Economics Sub-Committee (until

February 2017)

Member of EUROQOL

Member of EuroQOL Valuation Working Group

Member of NHMRC Research Committee

Chair, NHMRC Women in Health Science

Committee

Prof Jane Hall Board of the Bureau of Health Information Member of the Independent Hospital Pricing Authority (IPHA) Life Saving Drugs Program Reference Group. Review established by Commonwealth Department of Health Primary Health Care Research, Evaluation and Development Strategy Advisory Committee

Prof Marion Haas Chair of the UTS Human Research Ethics Committee (until December 2016) CANTEEN: Strategic Advisory Group re their Adolescent and Young Adults (AYA) work Cancer Australia: Gynaecological Cancer Advisory Group (GCAG) TransTasman Radiotherapy Oncology Group (TROG): Scientific Committee

Prof Stephen Goodall President of International Society for Pharmacoeconomics and Outcomes Research (ISPOR) – Australian Chapter UTS Ethics Committee – Clinical Trials sub-committee Editorial Board of the Health Technology Assessment (HTA) Glossary Food Standards Australia New Zealand Fellow

A/Prof Kees van Gool Evaluation Sub-Committee (ESC) of the Medical Services Advisory Committee (MSAC)

Patsy Kenny NSW Population and Health Services Research Ethics Committee

Dr Richard De Abreu Lourenço UTS Graduate Research School Board member

Paula Cronin Member of MSAC Economic Subcommittee

Dr Phil Haywood Protocol Advisory Sub-committee of the Medical Services Advisory Committee (MSAC)

Dr Alison Pearce UTS Research and Research Training Committee

Brendan Mulhern Student Member of ISPOR Australian Chapter

Sopany Saing General Committee Member of ISPOR Australian Chapter

VISITORS TO CHERE

Lisa Angus – Australian-American Health Policy Fellow Prof Denzil Fiebig – UNSW Prof Deborah Street – Mathematical Sciences, UTS (full time at CHERE from January 2017) Jesper van Breeschoten – Utrecht University, The Netherlands Qinglu Cheng – Queensland University of Technology Björn van Sambeek – Radbound University, The Netherlands Liza Sopina – University of Southern Denmark

VISITING SPEAKERS

Stefanie Schurer, Associate Professor in the School of Economics at the University of Sydney Topic: Early Life Health Interventions and Childhood Development: Evidence from Special Care Nursery Assignment in Australia's Northern Territory

Yuting Zhang, Associate Professor of Health Economics, and the founding Director of the Pharmaceutical Economics Research Group in the Department of Health Policy and Management at the University of Pittsburgh Topic: Improving Pharmaceutical Policy, Prescribing, and Use

Dr Thomas Round, GP and NIHR Doctoral Research Fellow, Department of Primary Care and Public Health Sciences, King’s College


London Topic: The relationship between primary care funding, secondary care utilisation and patient outcomes; Understanding variation in primary care referrals for suspected cancer

Jennie Hewitt, University of Sydney Topic: Falls prevention in residential aged care

Dr. Sau Nga Fu, Hospital Authority of Hong Kong Dr. Thomas Man Chi Dao, Hospital Authority of Hong Kong Topic: Health Related Quality of Life and the prevalence of undiagnosed Chronic Obstructive Pulmonary Disease (COPD) in patients attending primary care clinics with a history of smoking

Sophie Yan, UNSW Topic: Essential drugs list and zero profit policy: Has the Chinese government successfully reduced the burden on the rural patients?

Anna Hobbins, National University of Ireland, Galway Topic: Preview of EQ-5D-5L value set for Ireland

Esther De Bekker Grob, Erasmus University, The Netherlands Topic: External validity: a critical need for DCEs to take a key position in medical decision making

CURRENT PHD STUDENTS

Rebecca Addo PhD Topic: The Feasibility of Health Technology Assessment (HTA) in the Ghanaian Health System. Assessing the knowledge and attitudes of decision makers and researchers towards HTA in Ghana Supervisors: Prof Jane Hall, Prof Marion Haas, Prof Stephen Goodall

Sheena Arora PhD Topic: Economic evaluation of an intervention in parents with children who have developmental disabilities Supervisors: Prof Stephen Goodall, Prof Rosalie Viney, Prof Stewart Einfeld1 1. University of Sydney

Jody Church PhD Topic: Economics of Obesity

Supervisors: Prof Stephen Goodall, Prof Marion Haas, A/Prof Kees van Gool

Paula Cronin PhD Topic: Measuring the social and economic impact of communication disorders in Australia Supervisors: Prof Stephen Goodall, Dr Tricia McCabe1, Prof Rosalie Viney, Dr Rebecca Reeve2

1. University of Sydney 2. UNSW

Dr Philip Haywood PhD Topic: An outcome based reimbursement scheme for cancer pharmaceuticals Supervisors: Prof Marion Haas, Prof Rosalie Viney

Brendan Mulhern PhD Topic: Testing and advancing the methods used to develop and value preference based measures for use in economic evaluation Supervisors: Prof Rosalie Viney, Prof Debbie Street, Prof John Brazier1 1. University of Sheffield

Ros Prichard PhD Topic: The cost effectiveness of advanced heart failure management and mechanical circulatory assist therapy Supervisors: Prof Stephen Goodall, Trish Davidson, Chris Hayward

Mohammad Pulok PhD Topic: Measuring equity of access to health care in Australia: Evidence from administrative and survey data Supervisors: Prof Jane Hall and A/ Prof Kees van Gool Funding: UTS International Research Scholarship and CMCRC PhD scholarship Industry partner: National Health Performance Authority (NHPA)

Sopany Saing PhD Topic: Testing and advancing the methods used to develop and value preference based measures for use in economic evaluation Supervisors: Prof Stephen Goodall, Dr Naomi van der Linden, Prof Christopher Hayward1 1. St Vincent's Hospital

Dr Michael Wright PhD Topic: 21st Century Continuity of Care - Understanding Person and Place Based Continuity in Australian General Practice Supervisors: Prof Jane Hall, A/ Prof Kees van Gool, Prof Marion Haas


PEER-REVIEWED PUBLICATIONS 2017

Bagg, M.K., Hübscher, M., Rabey, M., Wand, B.M., O’Hagan, E., Moseley, L., Stanton, T.R., Maher, C.G., Goodall, S., Saing, S., O’Connell, N.E., Luomajoki, H. & McAuley, J.H. 2017, The RESOLVE Trial for people with Chronic Low Back Pain: Protocol for a randomised clinical trial. Journal of Physiotherapy, vol. 63, no. 1, pp. 47-48.

Carrara, S. & Longden, T. 2017, Freight futures: The potential impact of road freight on climate policy. Transportation Research Part D: Transport and Environment, (forthcoming).

Cronin, P.A., Kirkbidge, B., Bang, A., Smith, D., Parkinson, B. & Haywood, P. 2017. Long-term health care costs for patients with prostate cancer: A population-wide longitudinal study in New South Wales Australia. Asia Pacific Journal of Clinical Oncology, (forthcoming).

Cronin, P.A., Reeve, R., Viney, R., McCabe, P. & Goodall, S. 2017. The impact of childhood language difficulties on healthcare costs from 4 to 13 years: Australian longitudinal study. International Journal of Speech-Language Pathology, (forthcoming).

Daniels, B., Lord, S., Kiely, B., Houssami, N., Lu, C., Ward, R., Haywood, P. & Pearson, S. 2017, 'Use and outcomes of targeted therapies in early and metastatic HER2–positive breast cancer in Australia: Protocol detailing observations in a whole of population cohort', BMJ Open, 7:e014439.

De Abreu Lourenço, R., Haas, M., Hall, J. & Viney, R. 2017, 'Valuing meta-health effects for use in economic evaluations to inform reimbursement decisions: a review of the evidence', PharmacoEconomics, vol. 35, no. 3, pp. 347-362.

de Groot, S., van der Linden, N., Franken, M.G., Blommestein, H.M., Leeneman, B., van Rooijen, E., van der Hoeven, J.J.M., Wouters, M.W., Westgeest, H.M. & Uyl-de Groot, C.A. 2017, 'Balancing the Optimal and the Feasible: A Practical Guide for Setting Up Patient Registries for the Collection of Real-World Data for Health Care Decision Making Based on Dutch Experiences', Value in Health, vol. 20 no. 4, pp. 627-636.

Fiebig, D., Viney, R. C., Haas, M., Hole, A. R., Bateson, D., Street, D., Knox, S. (2017).

Consideration sets and their role in modelling doctor recommendations about contraceptives. Health Economics, vol. 26, no. 1, pp. 54-73.

Gu, M.Z. & Johar, M. 2017, 'Profiling hospital utilisation in a mixed public-private system', Applied Economics, vol. 49, no. 4, pp. 361-375.

Haeusler, G., Thursky, K., Mechinaud, F., Babl, F., De Abreu Lourenço, R., Slavin, M., & Phillips, B. (2017). ‘Predicting Infectious ComplicatioNs In Children with Cancer: an external validation study’. British Journal of Cancer (forthcoming).

Johar, M., Mu, C., van Gool, K. & Wong C.Y. 2017, 'Bleeding hearts, profiteers, or both specialist physician fees in an unregulated market', Health Economics, , vol. 26, no. 4, pp. 528-535.

Kenny PM, Goodall S, Street D, Greene J. 2017 ‘Choosing a Doctor: Does presentation format affect the way consumers use health care performance information? The Patient: Patient Centered Outcomes Research (forthcoming). McRae, I. & Van Gool, K. 2017, 'Variation in fees of medical specialists: problems, causes and solutions', Medical Journal of Australia, vol. 206, no. 4, pp. 162-163.

Luckett, T., Chenoweth, L., Phillips, J., Brooks, D., Cook, J., Mitchell, G., Pond, D., Davidson, P., Beattie, E., Luscombe, G., Goodall, S., Fischer, T. & Agar, M. 2017, 'A facilitated approach to family case conferencing for people with advanced dementia living in nursing homes: Perceptions of Palliative Care Planning Coordinators and other health professionals in the IDEAL Study', International Pscychogeriatrics (forthcoming).

Mu, C., De Abreu Lourenço, R. & van Gool, K. 2017, 'Is low priced primary care bad for quality? Evidence from Australian general practice', Applied Economics (forthcoming).

Mulhern, B., Norman, R., Lorgelly, P., Lancsar, E., Ratcliffe, J., Brazier, J. & Viney, R. 2017, Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration? PharmacoEconomics, vol. 35, no. 4, pp. 439-451.

Mulhern, B.J., Bansback, N., Hole, A.R. & Tsuchiya, A. 2017, Using Discrete Choice Experiment with duration to model EQ-5D-5L


health state preferences: Testing experimental design strategies. Medical Decision Making, vol. 37, no. 3, pp. 285-297.

Mulhern, B.J., Pink, J., Rowen, D., Borghs, S., Butt, T., Hughes, D., Marson, A. & Brazier, J. 2017, Comparing generic and condition specific preference based measures in epilepsy: EQ-5D-3L and NEWQOL-6D. Value in Health, vol. 20, no. 4, pp. 687-693.

Mulhern, B., Labeit, A., Rowen, D., Knowles, E., Meadows, K., Elliott, J. & Brazier, J. 2017, 'Developing preference-based measures for diabetes: DHP-3D and DHP-5D', Diabetic Medicine (forthcoming).

Nerich, V., Saing, S., Gamper, E.-.M., Holzner, B., Pivot, X., Viney, R. & Kemmler, G. 2017, 'Critical appraisal of health-state utility values used in breast cancer-related cost-utility analyses.', Breast Cancer Research and Treatment (forthcoming).

Nguyen, K.-.H., Mulhern, B., Kularatna, S., Byrnes, J., Moyle, W. & Comans, T. 2017, 'Developing a dementia-specific health state classification system for a new preference-based instrument AD-5D', Health and Quality of Life Outcomes, vol. 15.

Reeve, R., Srasuebkul, P., Langton, J., Haas, M.R., Viney, R. & Pearson, S.A. 2017, 'Health care use and costs at the end of life: A comparison of elderly Australian decedents with and without a cancer history', BMC Palliative Care.

Shah, K., Mulhern, B., Longworth, L. & Janssen, M.F. 2017, 'Views of the UK general public on important aspects of health not captured by EQ-5D', The Patient: Patient Centered Outcomes Research, (forthcoming).

Thomas, A.A., Pearce, A., Sharp, L., Gardiner, R.A., Chambers, S., Aitken, J., Molcho, M. & Baade, P. 2017, 'Socioeconomic disadvantage but not remoteness affects short-term survival in prostate cancer: A population-based study using competing risks', Asia-Pacific Journal of Clinical Oncology, vol. 13, no. 2, pp. e31-e40.

Wakefield, C., Fardell, J., Doolan, E., Drew, D., De Abreu Lourenço, R., Young, A. & Cohn, R. 2017, 'Grandparents of children with cancer: quality of life, medication and hospitalizations', Pediatric Blood and Cancer, vol. 64, no. 1, pp. 163-171.

Wong, C., Greene, J., Dolja-Gore, X. & van Gool, K. 2017, The rise and fall in out-of-pocket costs in Australia: An analysis of the

Strengthening Medicare Reforms. Health Economics, (forthcomimg).

CHERE WORKING PAPERS 2017

Comparing the UK EQ-5D-3L and English EQ-5D-5L value sets. CHERE Working Paper 2017/01 (PDF 1172KB). Authors: Brendan Mulhern, Yan Feng, Koonal Shah, Ben van Hout, Bas Janssen, Michael Herdman, and Nancy Devlin

CONFERENCE PRESENTATIONS 2017

De Abreu Lourenço, R. 2017, 'Estimating non (meta) health effects', ISPOR-AC Workshop, Sydney.

Oppe, M., Janssen, M.F., Luo, N., Mulhern, B. & Craig, B. 2017, 'DS-WG research: Where we are, how we got there, and where we are going', EuroQol Academy, Noordwijk, Netherlands.

Viney, R., Stolk, E., Mulhern, B., Norman, R. & Rand Hendriksen, K. 2017, 'DCE valuation of the EQ-5D: Lessons learned and remaining challenges', EuroQol Academy, Noordwijk, Netherlands.

Woods, M, 2017, 'Aged care reform', London School of Economics International Health Policy Conference.

Woods, M, 2017, 'Workshop on User Choice and Competition in Healthcare' (invited participant)., Productivity Commission.

Woods, M, 2017, 'The Future of Aged Care', Invited panellist, The Australian Newspaper.

Woods, M, 2017, 'Forum on Consumer Directed Care in residential aged care', guest speaker.

PEER-REVIEWED PUBLICATIONS 2016

Anazodo, A., Gerstl, B., Sullivan, E., Ledger, W., Orme, L., Stern, K., Viney, R.C., Gillam,

http://www.uts.edu.au/sites/default/files/wp2017_01.pdf




L., Jetti, M., Mclachlan, R., Jayasinghe, Y., Cohn, R., Wakefield, C., Dean, R., Agresta, F., Vu, J., Daly, E., Chan, D., Chapman, M., Kemertzis, M., Wand, H. & Gilbert, L. 2016, 'A Study Protocol for the Australasian Oncofertility Registry: Monitoring referral patterns and the uptake, quality and complications of fertility preservation strategies in Australia and New Zealand', Journal of Adolescent and Young Adult Oncology, vol. 5, no. 3, pp. 215-225.

Atukorale, Y.N., Church, J.L., Hoggan, B.L., Lambert, R.S., Gurgacz, S.L., Goodall, S. & Maddern, G.J. 2016, 'Self-Expanding Metallic Stents for the Management of Emergency Malignant Large Bowel Obstruction: a Systematic Review', Journal of Gastrointestinal Surgery, vol. 20, no. 2, pp. 455-462.

Bird, E.M. & Street, D.J. 2016, D-optimal asymmetric orthogonal array plus p run designs. Journal of Statistical Planning and Inference, vol. 170, pp. 64-76.

Bloem, L., De Abreu Lourenço, R., Chin, M., Ly, B. & Haas, M. 2016. Factors impacting treatment choice in the first-line treatment of colorectal cancer, Oncology and Therapy, vol. 4, no. 1, pp. 103-116.

Butler, K., Viney, R., van Gool, K., Arora, S., Goodall, S., Burns, L. Dunlop, A. (2016). The hidden costs of drug and alcohol use on hospital emergency departments. Drug and Alcohol Review, vol. 35, no. 3, pp. 359-366.

Butler, K., Reeve, R., Viney, R. & Burns, L. 2016, Estimating prevalence of drug and alcohol presentations to hospital emergency departments in NSW, Australia: impact of hospital consultation liaison services. Public Health Research & Practice, vol. 26: 4.

Cheng, Q., Church, J., Haas, M., Goodall, S., Sangster, J., & Furber, S. (2016). Cost-effectiveness of a population-based lifestyle intervention to promote healthy weight and physical inactivity in non-attenders of cardiac rehabilitation. Heart Lung and Circulation, 25, 265-274.

Gao L, Hu H, Zhao F-L, Li S-C (2016) Can the Direct Medical Cost of Chronic Disease Be Transferred across Different Countries? Using Cost-of-Illness Studies on Type 2 Diabetes, Epilepsy and Schizophrenia as Examples. PLoS ONE 11(1): e0147169.

Gardner, T., Refshauge, K., McAuley, J., Huebscher, M., Goodall, S., & Smith, L.

(2016). Patient led goal setting - a pilot study investigating a promising approach for the management of chronic low back pain. Spine vol. 41, no. 18, pp. 1405-1413.

Gu, M. & Johar, M. 2016, Economic Incentives in Health Care: The Case of Assigning Patients as “Not Ready for Care”. Economic Papers, vol. 35, no. 2, pp. 130-141.

Hall, J.P. & van Gool, K. 2016, Paying hospitals for quality: can we buy better care? Medical Journal of Australia, vol. 205, no. 10, pp. S27-S29.

Hole, A.R., Norman, R. & Viney, R. 2016, 'Response Patterns in Health State Valuation Using Endogenous Attribute Attendance and Latent Class Analysis', Health Economics, 25: 212-224.

Johnson, S., Clayton, S., Butow, P., Silvester, W., Detering, K., Hall, J.P., Kiely, B., Cebon, J., Clarke, S., Michael, N., Belle, M., Stockler, M., Beale, P. & Tattersall, M.H.N. 2016. Advance care planning in patients with incurable cancer: study protocol for a randomised controlled trial', BMJ Open, vol. 6, no. 12, pp. e012387-e012387.

Kenny, P., De Abreu Lourenço, R., Wong, C.Y., Haas, M. & Goodall, S. 2016, 'Community preferences in general practice: Important factors for choosing a general practitioner', Health Expectations, vol. 19, no. 1, pp. 26-38.

Kenny, P. M., Reeve, R., & Hall, J. (2016). Satisfaction with nursing education, job satisfaction and work intentions of new graduate nurses. Nurse Education Today, 36, 230-235.

King, M.T., Costa, D.S.J., Aaronson, N.K., Brazier, J.E., Cella, D.F., Fayers, P.M., Grimison, P., Janda, M., Kemmler, G., Norman, R., Pickard, A.S., Rowen, D., Velikova, G., Young, T.A. & Viney, R. 2016, 'QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30', Quality of Life Research, vol. 25, no. 3, pp. 625-636.

Langton, J., Reeve, R., Srasuebkul, P., Haas, M., Viney, R., Currow, D. & Pearson, S.A. 2016, 'Health service use and costs in the last six months of life in elderly decedents with a history of cancer: A comprehensive analysis from a health payer perspective', British


Journal of Cancer, vol. 114, no. 11, pp. 1293-1302.

Lee, B. S. B., Toh, S. -L., Ryan, S., Simpson, J. M., Clezy, K., Bossa, L, Rice S, Marial O, Weber G, Kaur J, Boswell-Ruys C, Goodall S, Middleton J, Tuderhope M, Kotsiou G. 2016. Probiotics (LGG-BB12 or RC14-GR1) versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury (ProSCIUTTU): a study protocol for a randomised controlled trial. BMC Urology vol. 16:18.

Mazza, D., Black, K., Taft, A., Lucke, J., McGeech, K., Haas, M.R., McKay, H. & Peipert, J. 2016, The Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial protocol. BMJ Open, vol. 6, no. 10, pp. e012491-e012491.

McCluskey, A., Ada, L., Kelly, P., Goodall, S., Middleton, S., Grimshaw, J., Logan, P., Longworth, M. & Karageorge, A. 2016, 'A behaviour change program to increase outings delivered during therapy to stroke survivors by community rehabilitation teams: The Out-and-About trial', International Journal of Stroke, vol. 11, no. 4, pp. 425-437.

Moullin J, Sabater-Hernández D, García-Corpas JP, Kenny P, Benrimoj S. Development and testing of two implementation tools to measure components of professional pharmacy service fidelity. Journal of Evaluation in Clinical Practice, vol. 22, no. 3, pp. 369-377.

Mulhern, B. J., Shah, K., Janssen, M. F., Ibbotson, R., & Longworth, L. (2016). Valuing health using Time Trade Off and Discrete Choice methods: Does dimension order impact on health state values? Value in Health, vol. 19, no. 2, pp. 210-217.

Nerich, V., Saing, S., Gamper, E.M., Kemmler, G., Daval, F., Pivot, X. & Holzer, B. 2016, Cost-utility analyses of drug therapies in breast cancer: a systematic review. Breast Cancer Research and Treatment, vol. 159, no. 3, pp. 407-424.

Norman, R., Kemmler, G., Viney, R., Pickard, A.S., Gamper, E., Holzner, B., Nerich, V. & King, M. 2016, Order of presentation of dimensions does not systematically bias utility weights from a discrete choice experiment. Value in Health, vol. 19, no. 8, pp. 1033-1038.

Norman, R., Mulhern, B. J., & Viney, R. (2016). The impact of different DCE-based

approaches when anchoring utility scores. PharmacoEconomics, vol. 34, no. 8, pp. 805-814.

Norman, R., Viney, R. C., Aaronson, N. K., Brazier, J. E., Cella, D., Costa, D. S., King, M. T. (2016). Using a discrete choice experiment to value the QLU-C10D: feasibility and sensitivity to presentation format. Quality of Life Research, vol. 25, no. 3, pp. 637-649.

Parkinson, B., Viney, R.C., Haas, M., Goodall, S., Srasuebkul, P. & Pearson, S.A. 2016. Real world evidence: a comparison of the Australian Herceptin Program and clinical trials of trastuzumab for HER2+ metastatic breast cancer. PharmacoEconomics, vol. 34, no. 10, pp. 1039-1050.

Pearce, A., Bradley, C., Hanly, P., O'Neill, C., Thomas, A.A., Molcho, M. & Sharp, L. 2016, Projecting productivity losses for cancer-related mortality 2011 - 2030. BMC Cancer, vol. 16, no. 1, p. 804.

Pearce, A.M., Ryan, F., Drummond, F.J., Thomas, A.A., Timmons, A. & Sharp, L. 2016, Comparing the costs of three prostate cancer follow-up strategies: a cost minimisation analysis. Supportive Care in Cancer, vol. 24, no. 2, pp. 879-886.

Rechel, B., Džakula, A., Duran, A., Fattore, G., Edwards, N., Grignon, M., Haas, M., Habicht, T., Marchildon, G.P., Moreno, A., Ricciardi, W., Vaughan, L. & Smith, T.A. 2016, Hospitals in rural or remote areas: An exploratory review of policies in 8 high-income countries. Health Policy, vol. 120, no. 7, pp. 758-769.

Rechel, B., McKee, M., Haas, M.R., Marchildon, G.P., Bousquet, F., Blümel, M., Geissler, A., van Ginneken, E., Ashton, T., Sperre Saunes, I., Anell, A., Quentin, W., Saltman, R., Culler, S.D., Barnes, A.J., Palm, W. & Nolte, E. 2016, Public reporting on quality, waiting times and patient experience in 11 high-income countries. Health Policy, vol. 120, no. 4, pp. 377-383.

Reeve, R., Arora, S., Butler, K., Viney, R., Burns, L., Goodall, S. & van Gool, K. 2016, Evaluating the impact of hospital based drug and alcohol consultation liaison services. Journal of Substance Abuse Treatment, vol. 68, pp. 36-45.

Scarf, V., Viney, R., & Homer, C. S. (2016). Costing alternative birth settings for women at low risk of complications: A systematic review. PLoS One, 11(2): e0149463.


Shah, K., Mulhern, B. J., Longworth, L., & Janssen, M. F. (2016). An empirical study of two alternative comparators for use in time-trade off studies. Value in Health, 19(1), 53-59.

Siva, S., Kron, T., Bressel, M., Haas, M. R., Mai, T., Vinod, S., et al. (2016). A Randomised Phase II Trial of Stereotactic Ablative Fractionated Radiotherapy versus Radiosurgery for Oligometastatic Neoplasia to the Lung (TROG 13.01 SAFRON II). BMC Cancer, 16:183.

Srivastava, R., Reynolds, G., Hall, J.P. & Downie, J. 2016, 'Costs of children with medical complexity in Australian public hospitals', Journal of Paediatrics and Child Health, vol. 52, no. 5, pp. 566-571.

van der Linden, M.C., Meester, B.E. & van der Linden, N. 2016, Emergency department crowding affects triage processes. International Emergency Nursing, vol.29, pp. 27-31.

van der Linden, N., Bongers, M.L., Coupé, V.M.H., Smit, E.F., Groen, H.J.M., Welling, A., Schramel, F.M.N.H. & Uyl-de Groot, C.A. 2016, 'Costs of non-small cell lung cancer in the Netherlands', Lung Cancer, vol. 91, pp. 79-88.

van der Linden, N., Buter, J., Pescott, C.P., Lalisang, R.I., de Boer, J.P., de Graeff, A., van Herpen, C.M., Baatenburg de Jong, R.J. & Uyl-de Groot, C.A. 2016, Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands. European Archives of Oto-Rhino-Laryngology, vol. 273, no. 2, pp. 455-464.

van Der Linden, N., Flach, G.B., De Bree, R. & Uyl-De Groot, C.A. 2016, 'Cost-utility of sentinel lymph node biopsy in cT1-T2N0 oral cancer', Oral Oncology, vol. 53, pp. 20-26.

van der Linden, N., van der Linden, M.C., Richards, J.R., Derlet, R.W., Grootendorst, D.C. & van den Brand, C.L. 2016, Effects of emergency department crowding on the delivery of timely care in an inner-city hospital in the Netherlands. European Journal of Emergency Medicine, vol. 23, no. 5, pp. 337-343.

Yu, S. 2016, Retiree welfare and the 2009 pension increase: Impacts from an Australian experiment. The Economic Record, (forthcoming).

BOOK CHAPTERS 2016

Hall, J.P. 2016, 'Maynard the globe trotter' in Cookson, R., Goddard, M. & Sheldon, T. (eds), Maynard Matters: Critical thinking on health policy, University of York, York, pp. 55-59.

Hall, J.P. & van Gool, K. 2016, 'Ageing, entitlement and funding health care' in Kendig, H., McDonald, P. & Piggott, J. (eds), Population ageing and Australia’s future, ANU Press, Canberra, pp. 261-279.

CHERE WORKING PAPERS 2016

Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England. CHERE Working Paper 2016/01 (PDF 962KB). Authors: Nancy Devlin, Koonal Shah, Yan Feng, Brendan Mulhern, Ben van Hout

New methods for modelling EQ-5D-5L value sets: an application to English data. CHERE Working Paper 2016/02 (PDF 748KB). Authors: Yan Feng, Nancy Devlin, Koonal Shah, Brendan Mulhern, Ben van Hout

APHCRI REPORTS 2016

REFinE-PHC: Patient Experiences of Primary Care (PDF 540KB). Authors: Marion Haas, Richard de Abreu Lourenço, and the REFinE Team

REFinE-PHC Paying for Primary Health Care: Financial incentives for efficiency, equity and sustainability (PDF 783KB). Authors: Jane Hall, Kees van Gool and the REFinE Team

REFinE-PHC Preferences and choice in primary care: Consumers and providers (PDF 524KB). Authors: Stephen Goodall, Patsy Kenny, Chunzhou Mu, Jane Hall, Richard Norman, Jackie Cumming, Debbie Street, Jessica Greene and the REFinE Team

The REFinE-PHC Primary Health Care in Australia: towards a more sustainable and equitable health care system (PDF 475KB). Authors: Kees van Gool, Jane Hall and the REFinE Team

http://www.uts.edu.au/sites/default/files/wp_2016_1a.pdf






http://www.uts.edu.au/sites/default/files/Patient-experiences-of-Primary-Health-Care-FullReport-FINAL.pdf

http://www.uts.edu.au/sites/default/files/Patient-experiences-of-Primary-Health-Care-FullReport-FINAL.pdf

http://www.uts.edu.au/sites/default/files/Paying-for-care-Full-Report-FINAL.pdf



http://www.uts.edu.au/sites/default/files/Preferences-and-choice-Full-Report-FINAL.pdf

http://www.uts.edu.au/sites/default/files/Preferences-and-choice-Full-Report-FINAL.pdf

http://www.uts.edu.au/sites/default/files/Sustainability-Full-Report-FINAL.pdf




CONFERENCE PRESENATIONS 2016

Agar, M., Luckett, T., Luscombe, G., Phillips, J., Beattie, E., Pond, D., Mitchell, G., Cook, J., Davidson, P.M., Brooks, D., Houltram, J., Goodall, S. & Chenoweth, L. 2016, 'Pragmatic cluster randomised controlled trial of facilitated family case conferencing versus usual care for people with advanced dementia living in aged care: effects on end of life care', Palliative Care Nurses Australia Conference, Canberra.

Arora, S., Goodall, S., Einfeld, S. & Viney, R. 2016, 'Using Discrete Choice experiments to value informal care provided to children with intellectual disabilities', ISPOR 7th Asia-Pacific Conference, Singapore.

Arora, S., Goodall, S., Viney, R. & Einfeld, S. 2016, 'Using a discrete choice experiment to value informal care provided to children with intellectual disabilities', 38th Annual Australian Health Economics Society Conference, Perth.

Cronin, P.A., Reeve, R., Goodall, S., Viney, R. & McCabe, P. 2016, 'A multilevel analysis of the role of academic school quality on academic outcomes for students with language difficulties', Longitudinal Data Conference, Canberra.

Cronin, P.A., Reeve, R., Goodall, S., Viney, R. & McCabe, P. 2016, 'The implications of school quality on the academic achievements of children with language difficulties', UTS Business School PhD Conference.

Cronin, P.A., Reeve, R., Goodall, S., Viney, R. & McCabe, T. 2016, 'The implications of school quality on the academic achievements of children with language difficulties', 38th Annual Australian Health Economics Society Conference, Perth.

De Abreu Lourenço, R. 2016, 'Incorporating Patient Values (Session Chair)', Room with a Patient View – Engaging patients in health care decision making, Sydney.

De Abreu Lourenço, R. 2016, 'Using health economics in radiotherapy research (Invited during plenary session)', TROG Annual Scientific Meeting.

De Abreu Lourenço, R., Haas, M., Hall, J., Parish, K., Stuart, D. & Viney, R. 2016, 'Placing a value on avoiding cancer recurrence: women’s preferences for contralateral prophylactic mastectomy', 38th

Annual Australian Health Economics Society Conference, Perth.

Goodall, S. 2016, 'Cost effectiveness of contrast-enhanced liver MRI in the characterisation of suspected liver lesions in patients with colorectal cancer', ISPOR 7th Asia-Pacific Conference, Singapore.

Goodall, S., Viney, R., Zhao, F-L. & Street, D. 2016, 'Estimating the impact of direct-to-consumer advertising of pharmacy only medicines using discrete choice experiments', ISPOR 7th Asia-Pacific Conference, Singapore.

Haas, M. & De Abreu Lourenço, R. 2016, 'The development and implementation of Health Economics in the SAFRON II trial protocol – an interactive workshop', TROG Annual Scientific Meeting.

Haas, M.R. 2016, 'Health Economics 101 (Invited during plenary session)', TROG Annual Scientific Meeting.

Kim, H., Liew, D. & Goodall, S. 2016, 'Clinical Trials for regulatory and reimbursement needs: Does one shoe fit all?', ISPOR 7th Asia-Pacific Conference, Singapore.

Longden, T., Wong, C.Y., Haywood, P., Hall, J. & van Gool, K. 2016, 'A question of persistence and related health states: an analysis of persistently high healthcare costs in the short term and long term', Australian Health Economics Society Conference, Fremantle, Australia.

Luckett, T., Chenoweth, L., Brooks, D., Cook, J., Mitchell, G., Pond, D., Beattie, E., Davidson, P.M., Luscombe, G., Goodall, S., Allsopp, J., Grover, S. & Agar, S. 2016, 'Implementing facilitated case conferencing for people living in aged care with advanced dementia: benefits, barriers and facilitators', Palliative Care Nurses Australia Conference, Canberra.

Meshcheriakova, E., Goodall, S. & Viney, R. 2016, 'Consumer preferences for food processing technologies: evidence from a discrete choice experiment', 38th Annual Australian Health Economics Society Conference, Perth.

Mulhern, B.J. & Brazier, J. 2016, 'Utility measures (Workshop)', ISPOR 21st Annual International Meeting, Washington DC.

Mulhern, B.J., De Abreu Lourenço, R. & Viney, R. 2016, 'Investigating the relative


value of health and social care related quality of life using discrete choice', 38th Annual Australian Health Economics Society Conference, Perth.

Pearce, A.M. 2016, 'Advances in Oncology: Can we afford the future? (Invited member of debate team)', Sydney Catalyst Education Dinner Series, Sydney.

Pearce, A.M. 2016, 'Moving cancer follow-up into primary care: Exploring the tension between outcomes, costs and patient preferences', Screening and Test Evaluation Program (STEP), University of Sydney.

Pearce, A.M. 2016, 'Moving cancer follow-up into primary care: Exploring the tension between outcomes, costs and patient preferences', Screening and Test Evaluation Program (STEP) Seminar, University of Sydney.

Pearce, A.M., Sharp, L., Gallagher, P., Timmons, A. & Watson, V. 2016, 'Pre-testing with cognitive interviewing highlights unanticipated decision making in a DCE', International Academy of Health Preference Research, Singapore.

Pearce, A.M., Sharp, L., Gallagher, P., Timmons, A. & Watson, V. 2016, 'Pre-testing with cognitive interviewing highlights unanticipated decision making in a DCE', 38th Annual Australian Health Economics Society Conference, Perth.

Prichard, R., Hayward, C., Davidson, P., Goodall, S. & Newton, P. 2016, 'Impact of Left Ventricular Assist Device Implantation on Hospitalisation, and Readmissions Using a Linked Administrative Dataset', Heart Lung and Circulation, The Cardiac Society of Australia and New Zealand, Elsevier, Adelaide, pp. S114-S114.

Prichard, R.A., Newton, P., Goodall, S., Kershaw, L., Davidson, P.M., Homer, T., McNeil, F. & Hayward, C.S. 2016, 'Establishing Institutional Costs in the Year Before and After VAD Implant and Before Heart Transplant', Journal of Heart And Lung Transplantation, pp. S272-S272.

Saing, S., Haywood, P. & Goodall, S. 2016, 'Cost effectiveness of contrast-enhanced liver MRI in the characterisation of suspected liver lesions in patients with colorectal cancer'.

Saing, S., Haywood, P. & Goodall, S. 2016, 'Economic evaluation of contrast-enhanced liver MRI in the characterisation of suspected

liver lesions', ISPOR Australia Chapter, Contemporary Economic Modelling: State of the Art, Sydney.

Saing, S., Kemmler, G., Gamper, E.M., Daval, F., Holzner, B., Pivot, X., Viney, R. & Nerich, V. 2016, 'Cost-utility analyses of drug therapies in breast cancer: a systematic review and critical appraisal of health-state utility values', 38th Annual Australian Health Economics Society Conference, Perth.

Scuffham, P., Viney, R. & Goodall, S. 2016, 'Risky Business: Decision making in Health Care with economic modelling', ISPOR 7th Asia-Pacific Conference, Singapore.

Tillemans, R., De Abreu Lourenço, R., Fardell, J.E., Wakefield, C.E., Signorelli, C., McLoone, J. & Cohn, R.J. 2016, 'What influences quality of life in paediatric cancer survivors?', ISOQOL 23rd Annual Conference, Copenhagen, Denmark.

Van Der Linden 2016, 'Cost-utility of sentinel lymph node biopsy in patients with cT1-T2N0 oral cancer', ISPOR Australia Chapter, Contemporary Economic Modelling Workshop.

Viney, R.C., Street, D., Norman, R. & Mulhern, B. 2016, 'Discrete Choice Experiments: An Introduction (Invited Workshop)', EuroQoL Mid Year Plenary Meeting, Nordwijk, Netherlands.

Wong, C., Longden, T., van Gool, K. & Hall, J. 2016, 'Morbidity interactions and the cost of healthcare: an analysis of a large‐ sample administrative dataset of primary care, hospital pharmaceutical and total healthcare costs', 38th Annual Australian Health Economics Society Conference, Perth.

Attendees at the ACORD 2016 workshop


Attendees of the 5th Meeting of the International Academy of Health Preference Research (IAHPR)

Alison Pearce presenting at the 5th Meeting of the International Academy of Health Preference Research (IAHPR)

Rosalie Viney presenting at the 5th Meeting of the International Academy of Health Preference Research (IAHPR)

Brendan Mulhern (CHERE) and Richard Norman, a collaborator from Curtin University, at the 5th Meeting of

the International Academy of Health Preference Research (IAHPR)

Fei-Li Zhao receiving her Excellent Article award

Sopany Saing at the ISPOR Conference

Fei-Li Zhao and Sopany Saing at the ISPOR Conference


Rosalie Viney, Stephen Goodall and Sopany Saing at the ISPOR Conference

Dr Richard De Abreu Lourenço, Profs Jane Hall, Attila Brungs, Marion Haas, Rosalie Viney, Graduation May 2017

Jody Church presenting her PhD at CHERE’s weekly seminar

annual report - home | university of technology sydney · conference presenations 2016 18. annual...

Documents